Showing results (1561-1570 of 1,955) with videos related to
Sort By:
Pageof 196
American Journal of Hematology|October 14, 2024
Characteristics and outcomes of incidentally diagnosed diffuse large B-cell lymphoma and implications for cancer screeningSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.Blood Cancer Journal|July 18, 2021
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab eraArushi Khurana, Raphael Mwangi, Stephen M Ansell, et al.JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.Journal of Personality Disorders|June 25, 2011
Personality assessment in DSM-5: empirical support for rating severity, style, and traitsChristopher J Hopwood, Johanna C Malone, Emily B Ansell, et al.Blood|March 19, 2011
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1Lucy S Hodge, Anne J Novak, Deanna M Grote, et al.Blood|July 18, 2008
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab eraThomas M Habermann, Sophia S Wang, Matthew J Maurer, et al.Acta Psychiatrica Scandinavica|October 15, 2008
Improvement in borderline personality disorder in relationship to ageM Tracie Shea, M O Edelen, A Pinto, et al.Journal of the American Heart Association|November 27, 2013
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillationBenjamin A Steinberg, Dajuanicia N Holmes, Jonathan P Piccini, et al.Investigational New Drugs|May 3, 2015
Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignanciesGuillermo Garcia-Manero, Raoul Tibes, Tapan Kadia, et al.Journal of Abnormal Psychology|August 19, 2009
Ten-year stability and latent structure of the DSM-IV schizotypal, borderline, avoidant, and obsessive-compulsive personality disordersCharles A Sanislow, Todd D Little, Emily B Ansell, et al.Pageof 196